112 related articles for article (PubMed ID: 26463)
1. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
[No Abstract] [Full Text] [Related]
2. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat.
Schut HA; Wirth PJ; Thorgeirsson SS
Mol Pharmacol; 1978 Jul; 14(4):682-92. PubMed ID: 683178
[No Abstract] [Full Text] [Related]
3. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
Schut HA; Thorgeirsson SS
Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
[No Abstract] [Full Text] [Related]
4. Mutagenic activation of N-hydroxy-2-acetylaminofluorene by developing epithelial cells of rat small intestine and effects of antioxidants.
Schut HA; Thorgeirsson SS
J Natl Cancer Inst; 1979 Dec; 63(6):1405-9. PubMed ID: 292812
[No Abstract] [Full Text] [Related]
5. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
[No Abstract] [Full Text] [Related]
6. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations.
Kurelec B; Krca S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481
[TBL] [Abstract][Full Text] [Related]
7. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
Glatt H; Oesch F
Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
[TBL] [Abstract][Full Text] [Related]
8. The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential.
McGregor D
Mutat Res; 1975 Dec; 30(3):305-15. PubMed ID: 1105163
[TBL] [Abstract][Full Text] [Related]
9. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
Stout DL; Baptist JN; Matney TS; Shaw CR
Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
[TBL] [Abstract][Full Text] [Related]
10. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
Kaneda S; Seno T; Takeishi K
J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
Stout DL; Becker FF
Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
[No Abstract] [Full Text] [Related]
13. Mutagenic activation of 2,4-diaminoanisole and 2-amino-fluorene by isolated rat liver nuclei and microsomes.
Aune T; Dybing E; Nelson SD
Chem Biol Interact; 1980 Jul; 31(1):35-49. PubMed ID: 6993025
[No Abstract] [Full Text] [Related]
14. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
Reddy TV; Weisburger EK; Thorgeirsson SS
J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
[TBL] [Abstract][Full Text] [Related]
15. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
Castro CE; Felkner IC; Yang SP
Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
[No Abstract] [Full Text] [Related]
16. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
[TBL] [Abstract][Full Text] [Related]
17. Effect of ascorbic acid on in vitro mutagenicity and in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in the rat.
Thorgeirsson SS; Sakai S; Wirth PJ
Mutat Res; 1980 May; 70(3):395-8. PubMed ID: 6155610
[No Abstract] [Full Text] [Related]
18. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
Hinson JA; Andrews LS; Gillette JR
Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
[No Abstract] [Full Text] [Related]
19. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
Rosin MP; Stich HF
Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 2-aminofluorene and 2-acetylaminofluorene to mutagens by rat hepatocyte nuclei.
Stout DL; Becker FF
Cancer Res; 1979 Apr; 39(4):1168-73. PubMed ID: 421200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
